title: Screening, evaluation and management of depression in people with diabetes in primary care.
abstract: Family physicians are responsible for diagnosing and treating the majority of people with type 2 diabetes mellitus and co-morbid depression. As a result of the impact of co-morbid depression on patient self-care and treatment outcomes, screening for depression in the context of a structured approach to case management and patient follow up is recommended in people with diabetes and cardiovascular disease. This review summarizes the need for improved recognition and treatment of depression in diabetes; and makes expert recommendations with regard to integrating screening tools and therapies into a busy family or general medical practice setting.
authors.affiliation: Diabetes Zentrum Mergentheim, Forschungsinstitut Diabetes-Akademie Bad Mergentheim (FIDAM GmbH), Bad Mergentheim, Germany. hermanns@diabetes-zentrum.de
authors.forename: Norbert
authors.initials: N
authors.lastname: Hermanns
authors.forename: Salvatore
authors.initials: S
authors.lastname: Caputo
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Dzida
authors.forename: Kamlesh
authors.initials: K
authors.lastname: Khunti
authors.forename: Luigi F
authors.initials: LF
authors.lastname: Meneghini
authors.forename: Frank
authors.initials: F
authors.lastname: Snoek
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy; D015897:Comorbidity; D003863:Depression / Q000175:diagnosis* / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000523:psychology*; D006801:Humans; D008403:Mass Screening / Q000379:methods; D011237:Predictive Value of Tests; D011320:Primary Health Care; D011569:Psychiatric Status Rating Scales; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents